The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Amlodipine Market Research Report 2024
Synopsis
Amlodipine, a calcium antagonist, can be used to treat various types of hypertension (alone or in combination with other drugs) and angina pectoris, especially spontaneous angina pectoris (alone or in combination with other drugs).This product has certain protective effect on kidney.The preparation includes amlodipine benzene sulfonate tablets, amlodipine mesylate tablets, levoamlodipine maleic acid tablets, etc.
The global Amlodipine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Amlodipine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Amlodipine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Amlodipine include Novartis, Pfizer, Lek, TEVA, Macleods Pharmaceuticals, Caraco Pharmaceutical, Sanis Health, Jamp Pharma and Accel Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Amlodipine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amlodipine.
Report Scope
The Amlodipine market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amlodipine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Pfizer
Lek
TEVA
Macleods Pharmaceuticals
Caraco Pharmaceutical
Sanis Health
Jamp Pharma
Accel Pharma
Jubilant Generics
Angita Pharma
Florida DOH Central Pharmacy
Shanghai Disainuo Biopharmaceutical
Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical
Beijing Wansheng Pharmaceutical
Beijing Honglin Pharmaceutical
Beijing Maidihai Pharmaceutical
China Resources Saike Pharmaceutical
Beijing Jiulong Pharmaceutical
Tiannian Pharmaceutical
Chengdu Diao Pharmaceutical Group
Yangtze Pharmaceutical
Kunming Sino Pharmaceutical
Wuhan Dongxin Pharmaceutical Technology
Jiangsu Wangao Pharmaceutical
Jiangsu Lianhuan Pharmaceutical
Jiangsu Huanghe Pharmaceutical
Zhejiang Jingxin Pharmaceutical
Zhejiang Jianfeng Pharmaceutical
Hunan Qianjinxieli Pharmaceutical
Segment by Type
by Product
Amlodipine Benzene Sulfonate Tablet
Amlodipine Mesylate Tablet
Levoamlodipine Maleic Acid Tablet
by Form
Tablets
Capsule
Segment by Application
High Blood Pressure
Angina Pectoris
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Amlodipine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Amlodipine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Amlodipine, a calcium antagonist, can be used to treat various types of hypertension (alone or in combination with other drugs) and angina pectoris, especially spontaneous angina pectoris (alone or in combination with other drugs).This product has certain protective effect on kidney.The preparation includes amlodipine benzene sulfonate tablets, amlodipine mesylate tablets, levoamlodipine maleic acid tablets, etc.
The global Amlodipine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Amlodipine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Amlodipine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Amlodipine include Novartis, Pfizer, Lek, TEVA, Macleods Pharmaceuticals, Caraco Pharmaceutical, Sanis Health, Jamp Pharma and Accel Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Amlodipine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amlodipine.
Report Scope
The Amlodipine market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amlodipine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Pfizer
Lek
TEVA
Macleods Pharmaceuticals
Caraco Pharmaceutical
Sanis Health
Jamp Pharma
Accel Pharma
Jubilant Generics
Angita Pharma
Florida DOH Central Pharmacy
Shanghai Disainuo Biopharmaceutical
Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical
Beijing Wansheng Pharmaceutical
Beijing Honglin Pharmaceutical
Beijing Maidihai Pharmaceutical
China Resources Saike Pharmaceutical
Beijing Jiulong Pharmaceutical
Tiannian Pharmaceutical
Chengdu Diao Pharmaceutical Group
Yangtze Pharmaceutical
Kunming Sino Pharmaceutical
Wuhan Dongxin Pharmaceutical Technology
Jiangsu Wangao Pharmaceutical
Jiangsu Lianhuan Pharmaceutical
Jiangsu Huanghe Pharmaceutical
Zhejiang Jingxin Pharmaceutical
Zhejiang Jianfeng Pharmaceutical
Hunan Qianjinxieli Pharmaceutical
Segment by Type
by Product
Amlodipine Benzene Sulfonate Tablet
Amlodipine Mesylate Tablet
Levoamlodipine Maleic Acid Tablet
by Form
Tablets
Capsule
Segment by Application
High Blood Pressure
Angina Pectoris
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Amlodipine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Amlodipine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Amlodipine Market Overview
1.1 Product Overview and Scope of Amlodipine
1.2 Amlodipine Segment by Product
1.2.1 Global Amlodipine Market Value Comparison by Product (2024-2030)
1.2.2 Amlodipine Benzene Sulfonate Tablet
1.2.3 Amlodipine Mesylate Tablet
1.2.4 Levoamlodipine Maleic Acid Tablet
1.3 Amlodipine Segment by Application
1.3.1 Global Amlodipine Market Value by Application: (2024-2030)
1.3.2 High Blood Pressure
1.3.3 Angina Pectoris
1.3.4 Other
1.4 Global Amlodipine Market Size Estimates and Forecasts
1.4.1 Global Amlodipine Revenue 2019-2030
1.4.2 Global Amlodipine Sales 2019-2030
1.4.3 Global Amlodipine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Amlodipine Market Competition by Manufacturers
2.1 Global Amlodipine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Amlodipine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Amlodipine Average Price by Manufacturers (2019-2024)
2.4 Global Amlodipine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Amlodipine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Amlodipine, Product Type & Application
2.7 Amlodipine Market Competitive Situation and Trends
2.7.1 Amlodipine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Amlodipine Players Market Share by Revenue
2.7.3 Global Amlodipine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Amlodipine Retrospective Market Scenario by Region
3.1 Global Amlodipine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Amlodipine Global Amlodipine Sales by Region: 2019-2030
3.2.1 Global Amlodipine Sales by Region: 2019-2024
3.2.2 Global Amlodipine Sales by Region: 2025-2030
3.3 Global Amlodipine Global Amlodipine Revenue by Region: 2019-2030
3.3.1 Global Amlodipine Revenue by Region: 2019-2024
3.3.2 Global Amlodipine Revenue by Region: 2025-2030
3.4 North America Amlodipine Market Facts & Figures by Country
3.4.1 North America Amlodipine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Amlodipine Sales by Country (2019-2030)
3.4.3 North America Amlodipine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Amlodipine Market Facts & Figures by Country
3.5.1 Europe Amlodipine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Amlodipine Sales by Country (2019-2030)
3.5.3 Europe Amlodipine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Amlodipine Market Facts & Figures by Country
3.6.1 Asia Pacific Amlodipine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Amlodipine Sales by Country (2019-2030)
3.6.3 Asia Pacific Amlodipine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Amlodipine Market Facts & Figures by Country
3.7.1 Latin America Amlodipine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Amlodipine Sales by Country (2019-2030)
3.7.3 Latin America Amlodipine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Amlodipine Market Facts & Figures by Country
3.8.1 Middle East and Africa Amlodipine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Amlodipine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Amlodipine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Amlodipine Sales by Type (2019-2030)
4.1.1 Global Amlodipine Sales by Type (2019-2024)
4.1.2 Global Amlodipine Sales by Type (2025-2030)
4.1.3 Global Amlodipine Sales Market Share by Type (2019-2030)
4.2 Global Amlodipine Revenue by Type (2019-2030)
4.2.1 Global Amlodipine Revenue by Type (2019-2024)
4.2.2 Global Amlodipine Revenue by Type (2025-2030)
4.2.3 Global Amlodipine Revenue Market Share by Type (2019-2030)
4.3 Global Amlodipine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Amlodipine Sales by Application (2019-2030)
5.1.1 Global Amlodipine Sales by Application (2019-2024)
5.1.2 Global Amlodipine Sales by Application (2025-2030)
5.1.3 Global Amlodipine Sales Market Share by Application (2019-2030)
5.2 Global Amlodipine Revenue by Application (2019-2030)
5.2.1 Global Amlodipine Revenue by Application (2019-2024)
5.2.2 Global Amlodipine Revenue by Application (2025-2030)
5.2.3 Global Amlodipine Revenue Market Share by Application (2019-2030)
5.3 Global Amlodipine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Amlodipine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Amlodipine Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Amlodipine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Amlodipine Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Lek
6.3.1 Lek Corporation Information
6.3.2 Lek Description and Business Overview
6.3.3 Lek Amlodipine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Lek Amlodipine Product Portfolio
6.3.5 Lek Recent Developments/Updates
6.4 TEVA
6.4.1 TEVA Corporation Information
6.4.2 TEVA Description and Business Overview
6.4.3 TEVA Amlodipine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 TEVA Amlodipine Product Portfolio
6.4.5 TEVA Recent Developments/Updates
6.5 Macleods Pharmaceuticals
6.5.1 Macleods Pharmaceuticals Corporation Information
6.5.2 Macleods Pharmaceuticals Description and Business Overview
6.5.3 Macleods Pharmaceuticals Amlodipine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Macleods Pharmaceuticals Amlodipine Product Portfolio
6.5.5 Macleods Pharmaceuticals Recent Developments/Updates
6.6 Caraco Pharmaceutical
6.6.1 Caraco Pharmaceutical Corporation Information
6.6.2 Caraco Pharmaceutical Description and Business Overview
6.6.3 Caraco Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Caraco Pharmaceutical Amlodipine Product Portfolio
6.6.5 Caraco Pharmaceutical Recent Developments/Updates
6.7 Sanis Health
6.6.1 Sanis Health Corporation Information
6.6.2 Sanis Health Description and Business Overview
6.6.3 Sanis Health Amlodipine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanis Health Amlodipine Product Portfolio
6.7.5 Sanis Health Recent Developments/Updates
6.8 Jamp Pharma
6.8.1 Jamp Pharma Corporation Information
6.8.2 Jamp Pharma Description and Business Overview
6.8.3 Jamp Pharma Amlodipine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Jamp Pharma Amlodipine Product Portfolio
6.8.5 Jamp Pharma Recent Developments/Updates
6.9 Accel Pharma
6.9.1 Accel Pharma Corporation Information
6.9.2 Accel Pharma Description and Business Overview
6.9.3 Accel Pharma Amlodipine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Accel Pharma Amlodipine Product Portfolio
6.9.5 Accel Pharma Recent Developments/Updates
6.10 Jubilant Generics
6.10.1 Jubilant Generics Corporation Information
6.10.2 Jubilant Generics Description and Business Overview
6.10.3 Jubilant Generics Amlodipine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Jubilant Generics Amlodipine Product Portfolio
6.10.5 Jubilant Generics Recent Developments/Updates
6.11 Angita Pharma
6.11.1 Angita Pharma Corporation Information
6.11.2 Angita Pharma Amlodipine Description and Business Overview
6.11.3 Angita Pharma Amlodipine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Angita Pharma Amlodipine Product Portfolio
6.11.5 Angita Pharma Recent Developments/Updates
6.12 Florida DOH Central Pharmacy
6.12.1 Florida DOH Central Pharmacy Corporation Information
6.12.2 Florida DOH Central Pharmacy Amlodipine Description and Business Overview
6.12.3 Florida DOH Central Pharmacy Amlodipine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Florida DOH Central Pharmacy Amlodipine Product Portfolio
6.12.5 Florida DOH Central Pharmacy Recent Developments/Updates
6.13 Shanghai Disainuo Biopharmaceutical
6.13.1 Shanghai Disainuo Biopharmaceutical Corporation Information
6.13.2 Shanghai Disainuo Biopharmaceutical Amlodipine Description and Business Overview
6.13.3 Shanghai Disainuo Biopharmaceutical Amlodipine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Shanghai Disainuo Biopharmaceutical Amlodipine Product Portfolio
6.13.5 Shanghai Disainuo Biopharmaceutical Recent Developments/Updates
6.14 Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical
6.14.1 Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Corporation Information
6.14.2 Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Amlodipine Description and Business Overview
6.14.3 Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Amlodipine Product Portfolio
6.14.5 Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Recent Developments/Updates
6.15 Beijing Wansheng Pharmaceutical
6.15.1 Beijing Wansheng Pharmaceutical Corporation Information
6.15.2 Beijing Wansheng Pharmaceutical Amlodipine Description and Business Overview
6.15.3 Beijing Wansheng Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Beijing Wansheng Pharmaceutical Amlodipine Product Portfolio
6.15.5 Beijing Wansheng Pharmaceutical Recent Developments/Updates
6.16 Beijing Honglin Pharmaceutical
6.16.1 Beijing Honglin Pharmaceutical Corporation Information
6.16.2 Beijing Honglin Pharmaceutical Amlodipine Description and Business Overview
6.16.3 Beijing Honglin Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Beijing Honglin Pharmaceutical Amlodipine Product Portfolio
6.16.5 Beijing Honglin Pharmaceutical Recent Developments/Updates
6.17 Beijing Maidihai Pharmaceutical
6.17.1 Beijing Maidihai Pharmaceutical Corporation Information
6.17.2 Beijing Maidihai Pharmaceutical Amlodipine Description and Business Overview
6.17.3 Beijing Maidihai Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Beijing Maidihai Pharmaceutical Amlodipine Product Portfolio
6.17.5 Beijing Maidihai Pharmaceutical Recent Developments/Updates
6.18 China Resources Saike Pharmaceutical
6.18.1 China Resources Saike Pharmaceutical Corporation Information
6.18.2 China Resources Saike Pharmaceutical Amlodipine Description and Business Overview
6.18.3 China Resources Saike Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2019-2024)
6.18.4 China Resources Saike Pharmaceutical Amlodipine Product Portfolio
6.18.5 China Resources Saike Pharmaceutical Recent Developments/Updates
6.19 Beijing Jiulong Pharmaceutical
6.19.1 Beijing Jiulong Pharmaceutical Corporation Information
6.19.2 Beijing Jiulong Pharmaceutical Amlodipine Description and Business Overview
6.19.3 Beijing Jiulong Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Beijing Jiulong Pharmaceutical Amlodipine Product Portfolio
6.19.5 Beijing Jiulong Pharmaceutical Recent Developments/Updates
6.20 Tiannian Pharmaceutical
6.20.1 Tiannian Pharmaceutical Corporation Information
6.20.2 Tiannian Pharmaceutical Amlodipine Description and Business Overview
6.20.3 Tiannian Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Tiannian Pharmaceutical Amlodipine Product Portfolio
6.20.5 Tiannian Pharmaceutical Recent Developments/Updates
6.21 Chengdu Diao Pharmaceutical Group
6.21.1 Chengdu Diao Pharmaceutical Group Corporation Information
6.21.2 Chengdu Diao Pharmaceutical Group Amlodipine Description and Business Overview
6.21.3 Chengdu Diao Pharmaceutical Group Amlodipine Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Chengdu Diao Pharmaceutical Group Amlodipine Product Portfolio
6.21.5 Chengdu Diao Pharmaceutical Group Recent Developments/Updates
6.22 Yangtze Pharmaceutical
6.22.1 Yangtze Pharmaceutical Corporation Information
6.22.2 Yangtze Pharmaceutical Amlodipine Description and Business Overview
6.22.3 Yangtze Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Yangtze Pharmaceutical Amlodipine Product Portfolio
6.22.5 Yangtze Pharmaceutical Recent Developments/Updates
6.23 Kunming Sino Pharmaceutical
6.23.1 Kunming Sino Pharmaceutical Corporation Information
6.23.2 Kunming Sino Pharmaceutical Amlodipine Description and Business Overview
6.23.3 Kunming Sino Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Kunming Sino Pharmaceutical Amlodipine Product Portfolio
6.23.5 Kunming Sino Pharmaceutical Recent Developments/Updates
6.24 Wuhan Dongxin Pharmaceutical Technology
6.24.1 Wuhan Dongxin Pharmaceutical Technology Corporation Information
6.24.2 Wuhan Dongxin Pharmaceutical Technology Amlodipine Description and Business Overview
6.24.3 Wuhan Dongxin Pharmaceutical Technology Amlodipine Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Wuhan Dongxin Pharmaceutical Technology Amlodipine Product Portfolio
6.24.5 Wuhan Dongxin Pharmaceutical Technology Recent Developments/Updates
6.25 Jiangsu Wangao Pharmaceutical
6.25.1 Jiangsu Wangao Pharmaceutical Corporation Information
6.25.2 Jiangsu Wangao Pharmaceutical Amlodipine Description and Business Overview
6.25.3 Jiangsu Wangao Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2019-2024)
6.25.4 Jiangsu Wangao Pharmaceutical Amlodipine Product Portfolio
6.25.5 Jiangsu Wangao Pharmaceutical Recent Developments/Updates
6.26 Jiangsu Lianhuan Pharmaceutical
6.26.1 Jiangsu Lianhuan Pharmaceutical Corporation Information
6.26.2 Jiangsu Lianhuan Pharmaceutical Amlodipine Description and Business Overview
6.26.3 Jiangsu Lianhuan Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2019-2024)
6.26.4 Jiangsu Lianhuan Pharmaceutical Amlodipine Product Portfolio
6.26.5 Jiangsu Lianhuan Pharmaceutical Recent Developments/Updates
6.27 Jiangsu Huanghe Pharmaceutical
6.27.1 Jiangsu Huanghe Pharmaceutical Corporation Information
6.27.2 Jiangsu Huanghe Pharmaceutical Amlodipine Description and Business Overview
6.27.3 Jiangsu Huanghe Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2019-2024)
6.27.4 Jiangsu Huanghe Pharmaceutical Amlodipine Product Portfolio
6.27.5 Jiangsu Huanghe Pharmaceutical Recent Developments/Updates
6.28 Zhejiang Jingxin Pharmaceutical
6.28.1 Zhejiang Jingxin Pharmaceutical Corporation Information
6.28.2 Zhejiang Jingxin Pharmaceutical Amlodipine Description and Business Overview
6.28.3 Zhejiang Jingxin Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2019-2024)
6.28.4 Zhejiang Jingxin Pharmaceutical Amlodipine Product Portfolio
6.28.5 Zhejiang Jingxin Pharmaceutical Recent Developments/Updates
6.29 Zhejiang Jianfeng Pharmaceutical
6.29.1 Zhejiang Jianfeng Pharmaceutical Corporation Information
6.29.2 Zhejiang Jianfeng Pharmaceutical Amlodipine Description and Business Overview
6.29.3 Zhejiang Jianfeng Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2019-2024)
6.29.4 Zhejiang Jianfeng Pharmaceutical Amlodipine Product Portfolio
6.29.5 Zhejiang Jianfeng Pharmaceutical Recent Developments/Updates
6.30 Hunan Qianjinxieli Pharmaceutical
6.30.1 Hunan Qianjinxieli Pharmaceutical Corporation Information
6.30.2 Hunan Qianjinxieli Pharmaceutical Amlodipine Description and Business Overview
6.30.3 Hunan Qianjinxieli Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2019-2024)
6.30.4 Hunan Qianjinxieli Pharmaceutical Amlodipine Product Portfolio
6.30.5 Hunan Qianjinxieli Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Amlodipine Industry Chain Analysis
7.2 Amlodipine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Amlodipine Production Mode & Process
7.4 Amlodipine Sales and Marketing
7.4.1 Amlodipine Sales Channels
7.4.2 Amlodipine Distributors
7.5 Amlodipine Customers
8 Amlodipine Market Dynamics
8.1 Amlodipine Industry Trends
8.2 Amlodipine Market Drivers
8.3 Amlodipine Market Challenges
8.4 Amlodipine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Amlodipine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Amlodipine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Amlodipine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Amlodipine Sales (KG) of Key Manufacturers (2019-2024)
Table 5. Global Amlodipine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Amlodipine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Amlodipine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Amlodipine Average Price (US$/G) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Amlodipine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Amlodipine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Amlodipine, Product Type & Application
Table 12. Global Key Manufacturers of Amlodipine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Amlodipine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amlodipine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Amlodipine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Amlodipine Sales by Region (2019-2024) & (KG)
Table 18. Global Amlodipine Sales Market Share by Region (2019-2024)
Table 19. Global Amlodipine Sales by Region (2025-2030) & (KG)
Table 20. Global Amlodipine Sales Market Share by Region (2025-2030)
Table 21. Global Amlodipine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Amlodipine Revenue Market Share by Region (2019-2024)
Table 23. Global Amlodipine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Amlodipine Revenue Market Share by Region (2025-2030)
Table 25. North America Amlodipine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Amlodipine Sales by Country (2019-2024) & (KG)
Table 27. North America Amlodipine Sales by Country (2025-2030) & (KG)
Table 28. North America Amlodipine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Amlodipine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Amlodipine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Amlodipine Sales by Country (2019-2024) & (KG)
Table 32. Europe Amlodipine Sales by Country (2025-2030) & (KG)
Table 33. Europe Amlodipine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Amlodipine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Amlodipine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Amlodipine Sales by Region (2019-2024) & (KG)
Table 37. Asia Pacific Amlodipine Sales by Region (2025-2030) & (KG)
Table 38. Asia Pacific Amlodipine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Amlodipine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Amlodipine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Amlodipine Sales by Country (2019-2024) & (KG)
Table 42. Latin America Amlodipine Sales by Country (2025-2030) & (KG)
Table 43. Latin America Amlodipine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Amlodipine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Amlodipine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Amlodipine Sales by Country (2019-2024) & (KG)
Table 47. Middle East & Africa Amlodipine Sales by Country (2025-2030) & (KG)
Table 48. Middle East & Africa Amlodipine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Amlodipine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Amlodipine Sales (KG) by Type (2019-2024)
Table 51. Global Amlodipine Sales (KG) by Type (2025-2030)
Table 52. Global Amlodipine Sales Market Share by Type (2019-2024)
Table 53. Global Amlodipine Sales Market Share by Type (2025-2030)
Table 54. Global Amlodipine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Amlodipine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Amlodipine Revenue Market Share by Type (2019-2024)
Table 57. Global Amlodipine Revenue Market Share by Type (2025-2030)
Table 58. Global Amlodipine Price (US$/G) by Type (2019-2024)
Table 59. Global Amlodipine Price (US$/G) by Type (2025-2030)
Table 60. Global Amlodipine Sales (KG) by Application (2019-2024)
Table 61. Global Amlodipine Sales (KG) by Application (2025-2030)
Table 62. Global Amlodipine Sales Market Share by Application (2019-2024)
Table 63. Global Amlodipine Sales Market Share by Application (2025-2030)
Table 64. Global Amlodipine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Amlodipine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Amlodipine Revenue Market Share by Application (2019-2024)
Table 67. Global Amlodipine Revenue Market Share by Application (2025-2030)
Table 68. Global Amlodipine Price (US$/G) by Application (2019-2024)
Table 69. Global Amlodipine Price (US$/G) by Application (2025-2030)
Table 70. Novartis Corporation Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 73. Novartis Amlodipine Product
Table 74. Novartis Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 78. Pfizer Amlodipine Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Lek Corporation Information
Table 81. Lek Description and Business Overview
Table 82. Lek Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 83. Lek Amlodipine Product
Table 84. Lek Recent Developments/Updates
Table 85. TEVA Corporation Information
Table 86. TEVA Description and Business Overview
Table 87. TEVA Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 88. TEVA Amlodipine Product
Table 89. TEVA Recent Developments/Updates
Table 90. Macleods Pharmaceuticals Corporation Information
Table 91. Macleods Pharmaceuticals Description and Business Overview
Table 92. Macleods Pharmaceuticals Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 93. Macleods Pharmaceuticals Amlodipine Product
Table 94. Macleods Pharmaceuticals Recent Developments/Updates
Table 95. Caraco Pharmaceutical Corporation Information
Table 96. Caraco Pharmaceutical Description and Business Overview
Table 97. Caraco Pharmaceutical Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 98. Caraco Pharmaceutical Amlodipine Product
Table 99. Caraco Pharmaceutical Recent Developments/Updates
Table 100. Sanis Health Corporation Information
Table 101. Sanis Health Description and Business Overview
Table 102. Sanis Health Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 103. Sanis Health Amlodipine Product
Table 104. Sanis Health Recent Developments/Updates
Table 105. Jamp Pharma Corporation Information
Table 106. Jamp Pharma Description and Business Overview
Table 107. Jamp Pharma Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 108. Jamp Pharma Amlodipine Product
Table 109. Jamp Pharma Recent Developments/Updates
Table 110. Accel Pharma Corporation Information
Table 111. Accel Pharma Description and Business Overview
Table 112. Accel Pharma Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 113. Accel Pharma Amlodipine Product
Table 114. Accel Pharma Recent Developments/Updates
Table 115. Jubilant Generics Corporation Information
Table 116. Jubilant Generics Description and Business Overview
Table 117. Jubilant Generics Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 118. Jubilant Generics Amlodipine Product
Table 119. Jubilant Generics Recent Developments/Updates
Table 120. Angita Pharma Corporation Information
Table 121. Angita Pharma Description and Business Overview
Table 122. Angita Pharma Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 123. Angita Pharma Amlodipine Product
Table 124. Angita Pharma Recent Developments/Updates
Table 125. Florida DOH Central Pharmacy Corporation Information
Table 126. Florida DOH Central Pharmacy Description and Business Overview
Table 127. Florida DOH Central Pharmacy Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 128. Florida DOH Central Pharmacy Amlodipine Product
Table 129. Florida DOH Central Pharmacy Recent Developments/Updates
Table 130. Shanghai Disainuo Biopharmaceutical Corporation Information
Table 131. Shanghai Disainuo Biopharmaceutical Description and Business Overview
Table 132. Shanghai Disainuo Biopharmaceutical Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 133. Shanghai Disainuo Biopharmaceutical Amlodipine Product
Table 134. Shanghai Disainuo Biopharmaceutical Recent Developments/Updates
Table 135. Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Corporation Information
Table 136. Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Description and Business Overview
Table 137. Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 138. Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Amlodipine Product
Table 139. Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Recent Developments/Updates
Table 140. Beijing Wansheng Pharmaceutical Corporation Information
Table 141. Beijing Wansheng Pharmaceutical Description and Business Overview
Table 142. Beijing Wansheng Pharmaceutical Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 143. Beijing Wansheng Pharmaceutical Amlodipine Product
Table 144. Beijing Wansheng Pharmaceutical Recent Developments/Updates
Table 145. Beijing Honglin Pharmaceutical Corporation Information
Table 146. Beijing Honglin Pharmaceutical Description and Business Overview
Table 147. Beijing Honglin Pharmaceutical Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 148. Beijing Honglin Pharmaceutical Amlodipine Product
Table 149. Beijing Honglin Pharmaceutical Recent Developments/Updates
Table 150. Beijing Maidihai Pharmaceutical Corporation Information
Table 151. Beijing Maidihai Pharmaceutical Description and Business Overview
Table 152. Beijing Maidihai Pharmaceutical Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 153. Beijing Maidihai Pharmaceutical Amlodipine Product
Table 154. Beijing Maidihai Pharmaceutical Recent Developments/Updates
Table 155. China Resources Saike Pharmaceutical Corporation Information
Table 156. China Resources Saike Pharmaceutical Description and Business Overview
Table 157. China Resources Saike Pharmaceutical Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 158. China Resources Saike Pharmaceutical Amlodipine Product
Table 159. China Resources Saike Pharmaceutical Recent Developments/Updates
Table 160. Beijing Jiulong Pharmaceutical Corporation Information
Table 161. Beijing Jiulong Pharmaceutical Description and Business Overview
Table 162. Beijing Jiulong Pharmaceutical Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 163. Beijing Jiulong Pharmaceutical Amlodipine Product
Table 164. Beijing Jiulong Pharmaceutical Recent Developments/Updates
Table 165. Tiannian Pharmaceutical Corporation Information
Table 166. Tiannian Pharmaceutical Description and Business Overview
Table 167. Tiannian Pharmaceutical Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 168. Tiannian Pharmaceutical Amlodipine Product
Table 169. Tiannian Pharmaceutical Recent Developments/Updates
Table 170. Chengdu Diao Pharmaceutical Group Corporation Information
Table 171. Chengdu Diao Pharmaceutical Group Description and Business Overview
Table 172. Chengdu Diao Pharmaceutical Group Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 173. Chengdu Diao Pharmaceutical Group Amlodipine Product
Table 174. Chengdu Diao Pharmaceutical Group Recent Developments/Updates
Table 175. Yangtze Pharmaceutical Corporation Information
Table 176. Yangtze Pharmaceutical Description and Business Overview
Table 177. Yangtze Pharmaceutical Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 178. Yangtze Pharmaceutical Amlodipine Product
Table 179. Yangtze Pharmaceutical Recent Developments/Updates
Table 180. Kunming Sino Pharmaceutical Corporation Information
Table 181. Kunming Sino Pharmaceutical Description and Business Overview
Table 182. Kunming Sino Pharmaceutical Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 183. Kunming Sino Pharmaceutical Amlodipine Product
Table 184. Kunming Sino Pharmaceutical Recent Developments/Updates
Table 185. Wuhan Dongxin Pharmaceutical Technology Corporation Information
Table 186. Wuhan Dongxin Pharmaceutical Technology Description and Business Overview
Table 187. Wuhan Dongxin Pharmaceutical Technology Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 188. Wuhan Dongxin Pharmaceutical Technology Amlodipine Product
Table 189. Wuhan Dongxin Pharmaceutical Technology Recent Developments/Updates
Table 190. Jiangsu Wangao Pharmaceutical Corporation Information
Table 191. Jiangsu Wangao Pharmaceutical Description and Business Overview
Table 192. Jiangsu Wangao Pharmaceutical Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 193. Jiangsu Wangao Pharmaceutical Amlodipine Product
Table 194. Jiangsu Wangao Pharmaceutical Recent Developments/Updates
Table 195. Jiangsu Lianhuan Pharmaceutical Corporation Information
Table 196. Jiangsu Lianhuan Pharmaceutical Description and Business Overview
Table 197. Jiangsu Lianhuan Pharmaceutical Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 198. Jiangsu Lianhuan Pharmaceutical Amlodipine Product
Table 199. Jiangsu Lianhuan Pharmaceutical Recent Developments/Updates
Table 200. Jiangsu Huanghe Pharmaceutical Corporation Information
Table 201. Jiangsu Huanghe Pharmaceutical Description and Business Overview
Table 202. Jiangsu Huanghe Pharmaceutical Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 203. Jiangsu Huanghe Pharmaceutical Amlodipine Product
Table 204. Jiangsu Huanghe Pharmaceutical Recent Developments/Updates
Table 205. Zhejiang Jingxin Pharmaceutical Corporation Information
Table 206. Zhejiang Jingxin Pharmaceutical Description and Business Overview
Table 207. Zhejiang Jingxin Pharmaceutical Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 208. Zhejiang Jingxin Pharmaceutical Amlodipine Product
Table 209. Zhejiang Jingxin Pharmaceutical Recent Developments/Updates
Table 210. Zhejiang Jianfeng Pharmaceutical Corporation Information
Table 211. Zhejiang Jianfeng Pharmaceutical Description and Business Overview
Table 212. Zhejiang Jianfeng Pharmaceutical Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 213. Zhejiang Jianfeng Pharmaceutical Amlodipine Product
Table 214. Zhejiang Jianfeng Pharmaceutical Recent Developments/Updates
Table 215. Hunan Qianjinxieli Pharmaceutical Corporation Information
Table 216. Hunan Qianjinxieli Pharmaceutical Description and Business Overview
Table 217. Hunan Qianjinxieli Pharmaceutical Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 218. Hunan Qianjinxieli Pharmaceutical Amlodipine Product
Table 219. Hunan Qianjinxieli Pharmaceutical Recent Developments/Updates
Table 220. Key Raw Materials Lists
Table 221. Raw Materials Key Suppliers Lists
Table 222. Amlodipine Distributors List
Table 223. Amlodipine Customers List
Table 224. Amlodipine Market Trends
Table 225. Amlodipine Market Drivers
Table 226. Amlodipine Market Challenges
Table 227. Amlodipine Market Restraints
Table 228. Research Programs/Design for This Report
Table 229. Key Data Information from Secondary Sources
Table 230. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Amlodipine
Figure 2. Global Amlodipine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Amlodipine Market Share by Type in 2023 & 2030
Figure 4. Amlodipine Benzene Sulfonate Tablet Product Picture
Figure 5. Amlodipine Mesylate Tablet Product Picture
Figure 6. Levoamlodipine Maleic Acid Tablet Product Picture
Figure 7. Global Amlodipine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Amlodipine Market Share by Application in 2023 & 2030
Figure 9. High Blood Pressure
Figure 10. Angina Pectoris
Figure 11. Other
Figure 12. Global Amlodipine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Amlodipine Market Size (2019-2030) & (US$ Million)
Figure 14. Global Amlodipine Sales (2019-2030) & (KG)
Figure 15. Global Amlodipine Average Price (US$/G) & (2019-2030)
Figure 16. Amlodipine Report Years Considered
Figure 17. Amlodipine Sales Share by Manufacturers in 2023
Figure 18. Global Amlodipine Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Amlodipine Players: Market Share by Revenue in 2023
Figure 20. Amlodipine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Amlodipine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Amlodipine Sales Market Share by Country (2019-2030)
Figure 23. North America Amlodipine Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Amlodipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Amlodipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Amlodipine Sales Market Share by Country (2019-2030)
Figure 27. Europe Amlodipine Revenue Market Share by Country (2019-2030)
Figure 28. Germany Amlodipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Amlodipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Amlodipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Amlodipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Amlodipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Amlodipine Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Amlodipine Revenue Market Share by Region (2019-2030)
Figure 35. China Amlodipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Amlodipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Amlodipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Amlodipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Amlodipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Amlodipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Amlodipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Amlodipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Amlodipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Amlodipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Amlodipine Sales Market Share by Country (2019-2030)
Figure 46. Latin America Amlodipine Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Amlodipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Amlodipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Amlodipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Amlodipine Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Amlodipine Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Amlodipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Amlodipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Amlodipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Amlodipine by Type (2019-2030)
Figure 56. Global Revenue Market Share of Amlodipine by Type (2019-2030)
Figure 57. Global Amlodipine Price (US$/G) by Type (2019-2030)
Figure 58. Global Sales Market Share of Amlodipine by Application (2019-2030)
Figure 59. Global Revenue Market Share of Amlodipine by Application (2019-2030)
Figure 60. Global Amlodipine Price (US$/G) by Application (2019-2030)
Figure 61. Amlodipine Value Chain
Figure 62. Amlodipine Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
